These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23857000)

  • 1. Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-γ and IL-2.
    Velásquez SY; García LF; Opelz G; Alvarez CM; Süsal C
    Transplantation; 2013 Jul; 96(2):154-61. PubMed ID: 23857000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral T lymphocyte cytokine profile (IFNgamma, IL-2, IL-4) and CD30 expression/release during measles infection.
    Vinante F; Krampera M; Morosato L; Rigo A; Romagnani S; Pizzolo G
    Haematologica; 1999 Aug; 84(8):683-9. PubMed ID: 10457402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro.
    Eichenauer DA; Simhadri VL; von Strandmann EP; Ludwig A; Matthews V; Reiners KS; von Tresckow B; Saftig P; Rose-John S; Engert A; Hansen HP
    Cancer Res; 2007 Jan; 67(1):332-8. PubMed ID: 17210715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
    Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte membrane antigen expression and intracellular cytokine patterns in an asymptomatic patient with persistently high serum levels of IgE.
    Krampera M; Antico A; Vinante F; Morosato L; Pizzolo G
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):144-8. PubMed ID: 10480588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological functions of CD30+ CD4+ T cells in rheumatoid arthritis.
    Okamoto A; Yamamura M; Iwahashi M; Aita T; Ueno A; Kawashima M; Yamana J; Kagawa H; Makino H
    Acta Med Okayama; 2003 Dec; 57(6):267-77. PubMed ID: 14726963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of CD30 and CD57 molecules on CD4(+) T cells from children with atopic asthma: a preliminary report.
    Rojas-Ramos E; Garfias Y; Jiménez-Martínez Mdel C; Martínez-Jiménez N; Zenteno E; Gorocica P; Lascurain R
    Allergy Asthma Proc; 2007; 28(6):659-66. PubMed ID: 18201430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection.
    Manetti R; Annunziato F; Biagiotti R; Giudizi MG; Piccinni MP; Giannarini L; Sampognaro S; Parronchi P; Vinante F; Pizzolo G; Maggi E; Romagnani S
    J Exp Med; 1994 Dec; 180(6):2407-11. PubMed ID: 7964515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines.
    Del Prete G; De Carli M; Almerigogna F; Daniel CK; D'Elios MM; Zancuoghi G; Vinante F; Pizzolo G; Romagnani S
    FASEB J; 1995 Jan; 9(1):81-6. PubMed ID: 7821763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct pattern of IL-2 and IFN-gamma gene expression in CD4 and CD8 T cells: cytofluorometric analysis at a single cell level using non-radioactive probes.
    Morvan PY; Picot C; Dejour R; Genetet B; Genetet N
    Cell Mol Biol (Noisy-le-grand); 1995 Nov; 41(7):945-57. PubMed ID: 8595373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of IFN-gamma-producing CD8+ gamma delta+ T lymphocytes and IL-2-producing CD4+ alpha beta+ T lymphocytes during contact sensitivity.
    Dieli F; Asherson GL; Sireci G; Dominici R; Sciré E; Salerno A
    J Immunol; 1997 Mar; 158(6):2567-75. PubMed ID: 9058788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo relevance of CD30 in atopic dermatitis.
    Caproni M; Bianchi B; D'Elios MM; De Carli M; Amedei A; Fabbri P
    Allergy; 1997 Nov; 52(11):1063-70. PubMed ID: 9404557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells.
    Briso EM; Dienz O; Rincon M
    J Immunol; 2008 Jun; 180(11):7102-6. PubMed ID: 18490707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.
    Kosaka A; Wakita D; Matsubara N; Togashi Y; Nishimura S; Kitamura H; Nishimura T
    Int Immunol; 2007 Mar; 19(3):249-56. PubMed ID: 17229818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.